服务热线
400-0689-033
| 品牌 | 货号 | 产品名称 | 描述 | CAS | 规格 | 单价（￥） | 货期 | 购买数量 |
|---|---|---|---|---|---|---|---|---|
| NIBSC | 09/196 | Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/222 | Human anti-Haemophilus influenzae b reference serum | European Certification | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/234 | Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-ß 3) (1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/236 | Influenza Virus Infectious IVR-153 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/242 | Fibrinogen Concentrate (B)(2nd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/260 | Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/264 | Fibrinogen Plasma (D)(3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/266 | GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF), human, rDNA-derived | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/268 | Influenza Virus Infectious NIBRG-121xp | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/272 | Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1) | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/274 | Influenza Virus Infectious NYMC X-185 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/280 | Influenza Virus Infectious NIB-64 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/284 | Anti-Human Neutrophil Antibody 1a WHO Reference Reagent | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/296 | Pro-Insulin, human (1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/304 | Influenza Virus Infectious IVR-155 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/306 | Influenza Virus Infectious NIBRG-147 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/308 | Influenza Serology Antigen Reagent X-179A (H1N1pdm) for HI Assay | Working Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/310 | Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 09/316 | Influenza Anti B Neuraminidase Serum (B/Florida/4/2006) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/104 | Reteplase Reference Material | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/120 | Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/128 | Diphtheria Polyclonal Antibody | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/130 | Diphtheria Monoclonal Antibody | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/132 | Tetanus Polyclonal Antibody | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/134 | Tetanus Monoclonal Antibody | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/140 | Anti-human papillomavirus[HPV] 18 serum (1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/142 | Negative control for Luminex based anti-HLA serology | European Certification | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/164 | Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain]. | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/168 | Oral Poliovaccine Sabin Type 3 reference | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/176 | Interleukin-29 (Interferon Lamda 1) | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/178 | Endotoxin (3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/198 | Anti-malaria (Plasmodium falciparum) human serum(1st International Reference Reagent) | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/202 | Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/214 | Influenza Anti N2 Neuraminidase Serum SH395 & SH396 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/218 | Influenza Anti A/California/7/2009 (N1) NA Serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/226 | Influenza Virus Infectious IVR-158 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/232 | Genomic DNA for blood group genotyping RBC1(AR1R1)(International Reference Reagent) | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/234 | Genomic DNA for blood group genotyping RBC12 (ODpsi)(International Reference Reagent) | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/236 | Genomic DNA for blood group genotyping RBC4(OR1R2)(International Reference Reagent) | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/238 | Genomic DNA for blood group genotyping RBC5(Brr)(International Reference Reagent) | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/242 | Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/252 | Factor VII Concentrate(2nd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/258 | Influenza Antigen A/California/7/2009-like(NIB-74) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/262 | Diphtheria Antitoxin Human IgG(1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/266 | 4th WHO International Standard for HBV DNA for NAT | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/272 | BCG vaccine of Moreau-RJ sub-strain(1st International Reference Reagent) | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/280 | Anti-HLA Control | European Certification | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/286 | Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 10/B596 | QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 1050 | IPV ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050) | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/106 | Influenza Virus infectious A/Perth/16/2009 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/108 | Influenza Virus infectious NYMC X-187 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/126 | Factors II and X Concentrate (4th International standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/130 | Influenza Virus Infectious NIBRG-14 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/134 | Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/170 | Erythropoietin, recombinant, for Bioassay (3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/176 | (3rd International Standard) Low Molecular Weight Heparin | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/184 | High Molecular Weight Urokinase(2nd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/206 | Influenza anti-A/Perth/16/2009 HA Serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/210 | Anti-human CD4 FITC conjugated 0.5ml | European Certification | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/214 | Blood Group Genotyping Reference Panel ((International Reference Reagent) | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/216 | Chagas Antibody Reference Panel ( 1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/218 | MLH1/MSH2 Exon Copy Number Reference Panel | European Certification | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/222 | Influenza Virus Infectious NIB-79 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/226 | Influenza Virus Infectious A/Victoria/361/2011 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/232 | Influenza Virus Infectious B/Texas/6/2011 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/234 | Immunoglobulin E(IgE) human serum (3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/242 | Viral Multiplex Reference | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/244 | Influenza Virus Infectiious NYMC BX-49 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/B604 | QCRFLUAH5QC1 Influenza H5 PC1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/B606 | QCRNEGQC1-Negative Quality Control Serum: Sample1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 11/B608 | QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/100 | Influenza Virus Infectious NYMC X-217 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/104 | International Standard for IPV 12/104 (3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/106 | Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/110 | Influenza Antigen B/Wisconsin/1/2010 (cell derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/112 | Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/114 | Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/116 | Influenza anti-A/Victoria/361/2011-like HA serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/118 | Influenza anti-B/Wisconsin/1/2010-like HA serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/122 | Influenza virus infectious A/turkey/Italy/3889/1999 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/154 | Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/176 | Methylated Human Serum Albumin (mHSA) | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/188 | Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived) (International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/198 | Influenza virus infectious B/Wisconsin/1/2010 34490 E5 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/202 | Influenza virus infectious NYMC BX-39 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/204 | Influenza Virus infectious IVR-165 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/208 | Parvovirus B19 (3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/224 | HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation) | International Reference Preparation | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/226 | HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/244 | Vi polysaccharide of C freundii WHO 1st International Standard | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/252 | ADAMTS 13 Plasma (1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/282 | Diphtheria Toxin 1Lf/ml | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/284 | Anti-meningococcal serogroup Y monoclonal antibody | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/290 | Influenza Virus Infectious B/Brisbane/36/2012 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/294 | Influenza Virus Infectious NYMC BX-51C | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/298 | Influenza Virus Infectious A/Texas/50/2012 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/306 | Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/B611 | Anti-VZV Quality control serum: Sample 1 QCRVZVIgMQC1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/B612 | QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 12/B613 | QCRRUBQC2-Anti-Rubella: Quality Control Serum: Sample 2 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/100 | Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/106 | Influenza Antigen B/Massachusetts/02/2012 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/108 | Anti-Meningococcal serogroup B monoclonal antibody | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/112 | Influenza Antigen A/Texas/50/2012 (NYMC X-223) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/116 | Influenza Antigen A/Texas/50/2012 (NYMC X-223A) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/122 | Erythropoietin Antibody Reference Panel Negative Control Antibody (1st WHO Reference Panel) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/126 | Influenza anti-B/Brisbane/60/2008-like HA serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/128 | Influenza Virus Infectious NIBRG-269 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/132 | Antibodies, Human, to Toxoplasma gondii (4th International Standard). | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/134 | Influenza Antigen B/Massachusetts/02/2012 (Egg derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/146 | C-Peptide, Human (1st International Standard). | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/152 | Influenza Antigen B/Massachusetts/02/2012 (cell derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/162 | Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/164 | Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/166 | Influenza anti-A/Anhui/1/2013 (N9) NA Serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/168 | Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques | Clinical Virology Network | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/172 | Lupus Anticoagulant (1st International Reference Panel) | International Reference Preparation | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/176 | Influenza Virus Infectious NIBRG-88 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/178 | Influenza Anti-A/Texas/50/2012-like HA Serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/182 | Influenza Anti-B/Massachusetts/02/2012-like HA Serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/198 | Influenza Virus Infectious NYMC X-181 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/200 | Influenza Virus Infectious NIB-74 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/202 | Influenza Virus Infectious NIB-74xp | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/204 | TNF Rec II- FC Fusion protein (1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/206 | Plasmin (4th International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/212 | Diphtheria Toxoid for use in Flocculation Test (3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/214 | HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel) | International Reference Preparation | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/216 | Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/218 | Polio Anti Sabin type 1 (inactivated) Serum | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/220 | Polio Anti Sabin type 2 (inactivated) serum | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/222 | Polio Anti Sabin type 3 (inactivated) serum | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/224 | Influenza virus Infectious NIB-85. 36210 E5 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/228 | Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/234 | Influenza antigen B/Brisbane/60/08 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/238 | Anti-EV71 serum LOW (WHO International Reference Reagent) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/242 | FEIBA Concentrate 2nd NIBSC Working Reference Standard | Working Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/246 | Meningococcal serogroup A polysaccharide (1st WHO International Standard). | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/248 | Influenza virus infectious NIBRG-267 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/250 | Influenza Virus Infectious NIBRG-268 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/252 | Influenza virus infectious NYMC X-223A | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/256 | Influenza virus infectious. NYMC x-233 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/258 | Influenza virus infectious NYMC X-233A | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/262 | Meningococcal serogroup A polysaccharide | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/264 | Influenza Virus Infectious NYMC X-223 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/B627 | QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/B629 | QCRHBeQC1-Anti-HBe Quality Control Serum: sample1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/B634 | QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/B636 | QCRHIV1QC2- Anti-HIV 1: Quality Control Serum: Sample 2 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/B640 | QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/B642 | QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/B644 | QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 13/B650 | QCRCMVQC1- Anti CMV: Quality Control Serum: Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/106 | Influenza virus infectious. NYMC BX-51B | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/114 | JC Virus (JCV) DNA (1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/116 | Influenza virus infectious NYMC X-179A | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/118 | Influenza virus infectious B/Massachusetts/2/2012 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/140 | 1st International Standard for Anti EV71 Serum Human | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/144 | Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/146 | Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/148 | Human Blood Factor IX Concentrate (5th International Standard). | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/150 | Hepatitis C virus (HCV) For nucleic acid amplification techniques (5th International standard 2015) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/156 | Meningococcal group X polysaccharide (1st WHO International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/160 | High titre anti-A in IVIG working reference reagent | Working Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/174 | Botulinum Type A Antitoxin, Equine | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/198 | HBV,HCV,HIV Multiplex | European Certification | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/200 | Influenza Antigen A/Puerto Rico/8/34 (HINI) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/204 | Influenza Virus Infectious B/Brisbane/9/2014 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/206 | Influenza virus infectious NYMC X-247 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/210 | Biological activities of Rituximab WHO 1st International Standard | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/212 | BK Virus (BKV)(1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/224 | Influenza virus infectious. A/Switzerland/9715293/2013 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/226 | Influenza Virus Infectious A/South Australia/55/2014 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/228 | Influenza Virus Infectious A/Stockholm/6/2014 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/230 | Influenza Virus Infectious. A/Norway/466/2014 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/232 | Influenza Virus Infectious IVR-175 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/240 | British Working Standard for Anti-HCV | European Certification | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/242 | Anti-HCV (1 in 8 dilution)(British Working Standard) | European Certification | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/246 | Influenza Virus Infectious NIBRG-301 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/254 | Influenza Antigen A/Switzerland/9715293/2013 (NIB88) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/274 | Influenza Antigen B/Brisbane/9/2014 (Egg Derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/290 | 4th HCV RNA Genotype Panel for Nucleic Acid Amplification | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/300 | High titre anti-A and anti-B in serum (WHO Reference Reagent). | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/306 | Influenza Virus Infectious NYMC X-243 40180 E13 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/308 | Influenza Virus Infectious IVR-178 40200 E7 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/314 | Influenza Virus Infectious NIB-88 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/316 | Factor IX activated (FIXa) 2nd WHO International Standard | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/318 | Influenza Anti NIBRG-301 (H5) HA Serum (Sheep SH624 and SH625) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/320 | Influenza Virus Infectious B/Utah/9/2014 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/322 | Influenza Virus Infectious NIB-91 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/B651 | QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/B653 | QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/B654 | QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 14/B655 | QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/100 | Influenza Antigen B/Utah/9/2014 (Cell Derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/102 | Activated Blood Coagulation Factor X (FXa), Human | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/104 | Influenza Antigen A/South Australia/55/2014 Cell derived | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/106 | Ancrod | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/126 | Bordetella pertussis toxin (20µg). (2nd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/130 | Clinical Virology Multiplex I: Immunodeficiency panel working reagent for Nucleic Acid Amplification Tests (NAT) | Clinical Virology Network | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/134 | Influenza Anti-A Switzerland/9715293/2013-Like HA serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/136 | EBOV RNA NP-VP35-GP in-run control | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/138 | EBOV RNA VP40-L in-run control | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/140 | Batroxobin | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/146 | Influenza Virus Infectious B/Brisbane/60/2008 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/148 | Influenza Virus Infectious NIB-92 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/150 | Influenza anti-B/Phuket/3073/2013 HA serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/154 | Influenza Virus Infectious NIB-93 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/158 | Influenza Virus Infectious NYMC X-263 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/160 | Influenza Virus Infectious NIBRG-306 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/174 | Lupus (oligo-specific) anti-dsDNA antibodies WHO Reference Reagent | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/180 | Blood Coagulation Factor XI, 2016 Plasma Human (2nd International Standard). Blood Coagulation Factor XII, 2017 Plasma, Human (1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/182 | 7th British Working Standard for Blood Coagulation Factors II, IX, X Concentrate | Working Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/184 | Influenza Virus Infectious NYMC X-263B | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/188 | Influenza Virus Infectious NYMC X-263A | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/192 | Influenza Virus Infectious A/Hong Kong/4801/2014 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/194 | Influenza Virus Infectious NYMC X-257A | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/196 | Influenza Virus Infectious NYMC X-261 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/212 | Influenza Virus Infectious NYMC BX-53C | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/220 | Anti-EBOV plasma, human (WHO Reference Reagent) | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/222 | EBOV RNA NP-VP35-GP (WHO Reference Reagent) | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/224 | EBOV RNA VP40-L (WHO Reference Reagent) | International Reference Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/234 | Influenza Virus Infectious B/Texas/2/2013 41340 E7 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/238 | Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/240 | Erythropoietin Antibody Reference Panel A (1st WHO Reference Panel) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/242 | Erythropoietin Antibody Reference Panel B (1st WHO Reference Panel) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/248 | Influenza Anti A/Anhui/1/2013 (H7) HA Serum (Sheep SH644 & SH645) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/250 | Influenza Virus Infectious NYMC BX-31 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/252 | Influenza Virus Infectious A/California/7/2009 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/262 | 1st International Standard for Ebola virus (EBOV) antibodies Sierra Leone Convalescent Plasma Pool | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/266 | HHV-6 Virus 1st WHO International Standard | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/274 | Influenza Virus Infectious NYMC BX-59A | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/276 | Hepatitis A Virus (3rd International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/294 | Influenza virus infectious NYMC BX-59B | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/296 | Sabin monovalent Polio vaccine type 2 (1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/298 | Influenza Virus Infectious B/Brisbane/46/2015 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/300 | Influenza Virus Infectious NYMC BX-35 41950 E11 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/304 | Parathyroid hormone 1-34, recombinant, human, 2nd WHO International Standard | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/312 | Influenza Anti-B/Brisbane/60/2008 HA Serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B658 | QCRLYMEQC1 - Anti-Lyme QC1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B661 | QCRLYMEIgMQC1 - IgM Anti-Lyme QC1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B664 | QCRMUMPSQC1 - Anti-Mumps Quality Control Reagent Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B667 | QCRMEASQC1 Anti-MeaslesQC1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B669 | QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B671 | QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B673 | QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B678 | QCRPARVB19QC1 Anti-Parvovirus B19QC1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 15/B680 | QCRHBsQC1- Anti HBs Quality Control Serum: Sample 1 | Quality Control Reagent | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/104 | Norovirus GII Working reagent for Nucleic Acid Amplification Techniques | Clinical Virology Network | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/106 | Influenza antigen A/California/7/09 (H1N1) (NYMC-X181) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/108 | Influenza Virus Infectious A/PR/8/34 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/114 | Influenza anti - A/California/7/09 HA serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/118 | Influenza Antigen B/Brisbane/60/2008 (NYMC BX-35) (Egg Derived) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/120 | WHO 1st International Reference Panel for Genomic JAK2 V617F | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/124 | Zika Virus run Control (NAT) | Clinical Virology Network | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/126 | Native Vi polysaccharide (S. Typhi) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/138 | Anti-Typhoid capsular Vi polysaccharide Ig (Human) 1st WHO International Standar | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/154 | Blood Virology Multiplex II | Clinical Virology Network | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/158 | Influenza Antigen B/Phuket/3073/2013 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/164 | WHO OPV Reference bOPV 1+3 | Non WHO Reference Material | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/170 | Infliximab(1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/182 | Influenza Anti-A/Hong Kong/4801/2014-like HA Serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/192 | Influenza Anti-B/Brisbane/60/2008 HA serum | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/194 | HIV-1 RNA (4th International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/196 | Sabin monovalent Polio vaccine type 1(1st International Standard) | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/200 | Influenza Virus Infectious NIB-58 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/208 | Influenza Virus Infectious NIB-97 42090 E7 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/238 | Influenza Antigen A/Anhui/1/2013 (NIBRG-268) (H7N9) | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/242 | Influenza Virus Infectious NIB-98 42110 E7 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/248 | Influenza Virus Infectious NYMC X-275 42020 E11 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/250 | 1st International Reference Panel for genomic KRAS codons 12 and 13 mutations | International Standard | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/268 | Influenza Virus Infectious X-273 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/270 | Influenza Virus Infectious IVR-180 42400 E3/D7/E1 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/274 | Influenza Virus Infectious X-275A 42010 E13 | Influenza | vial |
0.00
0.00 |
咨询 |
|
|
| NIBSC | 16/282 | Influenza Virus Infectious X-285 42430 ExE1 | Influenza | vial |
0.00
0.00 |
咨询 |
|